Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Array BioPharma revenue
Array BioPharma's revenue is $173.8 million.
What is Array BioPharma's revenue?
- Array BioPharma's revenue growth from 2001 to 2018 is 921.82%.
- Array BioPharma has 298 employees, and the revenue per employee ratio is $583,114.
- Array BioPharma's peak quarterly revenue was $82.5M in 2019(q2).
- Array BioPharma peak revenue was $173.8M in 2018.
- Array BioPharma annual revenue for 2017 was 150.9M, 9.41% growth from 2016.
- Array BioPharma annual revenue for 2018 was 173.8M, 15.19% growth from 2017.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Array BioPharma historical revenue
Array BioPharma's peak revenue was $173.8M in 2018. The peak quarterly revenue was $82.5M in 2019(q2).
Array BioPharma's revenue increased from $17.0m in 2001 to $173.8M currently. That's a 921.82% change in annual revenue.
Array BioPharma annual revenue
Array BioPharma annual revenue over time
| Fiscal year / year | Array BioPharma revenue |
|---|---|
| 2009 | $25.0M |
| 2010 | $53.9M |
| 2011 | $71.9M |
| 2012 | $85.1M |
| 2013 | $69.6M |
| 2014 | $42.1M |
| 2015 | $51.9M |
| 2016 | $137.9M |
| 2017 | $150.9M |
| 2018 | $173.8M |
How accurately did Array BioPharma's revenue projections match actual performance?
Array BioPharma annual growth
Array BioPharma saw the greatest revenue growth in 2016, when revenue increased by 165.62%.
Array BioPharma had the lowest revenue growth in 2014, when revenue changed by -39.53%.
Array BioPharma annual growth rate over time
| Year | Array BioPharma growth |
|---|---|
| 2009 | -13%↓ |
| 2010 | 116%↑ |
| 2011 | 33%↑ |
| 2012 | 18%↑ |
| 2013 | -18%↓ |
| 2014 | -40%↓ |
| 2015 | 23%↑ |
| 2016 | 166%↑ |
| 2017 | 9%↑ |
| 2018 | 15%↑ |
Array BioPharma quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Array BioPharma quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $5.7M | $7.7M | $6.0M | $5.5M |
| 2010 | $7.9M | $9.6M | $18.4M | $18.0M |
| 2011 | $18.5M | $16.5M | $17.8M | $19.0M |
| 2012 | $22.1M | $23.2M | $19.1M | $20.7M |
| 2013 | $15.8M | $18.4M | $10.0M | $25.4M |
| 2014 | $14.2M | $14.1M | $7.8M | $6.0M |
| 2015 | $6.1M | $26.9M | $6.6M | $12.3M |
| 2016 | $16.2M | $35.4M | $43.0M | $43.2M |
| 2017 | $39.3M | $44.5M | $33.3M | $33.8M |
| 2018 | $29.7M | $42.2M | $66.4M | $35.4M |
| 2019 | $56.9M | $82.5M | $64.7M | - |
Array BioPharma jobs nearby
Do you work at Array BioPharma?
Did Array BioPharma meet its revenue projections?
Array BioPharma financial information
| CEO | Ron Squarer |
| Company Type | Public |
| Employees Number | 298 |
| Date Founded | 1998 |
| Headquarters | Boulder, Colorado |
| Number of Locations | 1 |
| Revenue | $173.8M |
| Net Income | -$147,346,000 |
| Gross Proft | $114.4M (2018) |
| PE Ratio | -27.76 |
| Tax Rate | -0.0% |
| Market Capitalization | $4.1B |
| Total Assets | $460,364,000 |
| Ticker | ARRY_delis |
Array BioPharma jobs you might like
Array BioPharma financing
Array BioPharma received early financing of $80.0M on 2008-05-06.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Debt | $80M | 05/2008 |
| Post Ipo Debt | $40M | 05/2009 |
| Post Ipo Equity | $1.4M | 09/2016 |
Array BioPharma investors
| Investors | Security type |
|---|---|
| Deerfield | Post Ipo Debt |
| Deerfield Management | Post Ipo Debt |
| Deerfield | Post Ipo Debt |
| Deerfield Management | Post Ipo Debt |
| Redmile Group | Post Ipo Equity |
Array BioPharma competitors
Array BioPharma's top competitor, Merck, earned an annual revenue of $64.2B.
Array BioPharma's smallest competitor is Arena Pharmaceuticals with revenue of $54.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Seagen | $85,008 | $2.0B | 900 | - |
| Sarepta Therapeutics | $94,985 | $1.9B | 840 | 21 |
| Exelixis | $108,978 | $2.2B | 484 | 175 |
| Regeneron | $85,589 | $14.2B | 9,123 | 341 |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 702 |
| ImmunoGen | $64,247 | $108.8M | 75 | - |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 148 |
| Merck | $90,328 | $64.2B | 74,000 | 1,570 |
| Forest Laboratories | $91,901 | $3.6B | 6,200 | - |
| Genocea | $53,221 | - | 59 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Array BioPharma highest paying jobs
Zippia gives an in-depth look into the details of Array BioPharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Array BioPharma. The employee data is based on information from people who have self-reported their past or current employments at Array BioPharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Array BioPharma. The data presented on this page does not represent the view of Array BioPharma and its employees or that of Zippia.
Array BioPharma may also be known as or be related to ARRAY BIOPHARMA INC, Array BioPharma, Array BioPharma Inc. and Array Biopharma Inc.